Wire · opportunities
Micron Biomedical lands $4.5 million contract for microneedle patch
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 5 August 2026 · Fusion42 review
Micron Biomedical secured a $4.5 million contract with NIAID to develop a microneedle patch for treating Acute Radiation Syndrome using their dissolvable microarray drug delivery technology combined with Connext's TLR5 agonist. The patch is designed for rapid, painless self-administration, stability without refrigeration, and stockpiling for emergency use, with market introduction targeted by 2028.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
You can bypass cold-chain hurdles and simplify deployment by building on Micron's painless microneedle platform for rapid self-administration in emergencies. That shifts your product focus from traditional injections to accessible, stockpiled treatment ready for quick use in disaster zones.
◆ Coverage
1 source · 4 Aug 2026
◆ Related on Wire
◆ Topics